Our findings suggest that there may be a role for genetic testing to identify individuals in whom vitamin D supplementation should be used with caution and to facilitate a precision-medicine approach for the treatment of recurrent kidney stone disease, whereby targeting of the CaSR-signaling or vitamin D metabolism pathways may be beneficial in the treatment of a subset of patients with nephrolithiasis; further studies are required. Here, CASR is linked to nephrolithiasis.